Veracyte Names Angeline McCabe as Vice President, Investor Relations and Corporate Communications
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT) today announced that the company has named Angeline (“Angie”) McCabe as vice president, investor relations and corporate communications, effective immediately. In this role, Ms. McCabe will be responsible for the development and execution of Veracyte’s communications strategy to internal and external stakeholders, including shareholders, customers, and employees. Prior to joining Veracyte, Ms. McCabe served as vice president, investor relations at WellCare Health Plans, Inc. Previously, she held investor relations and corporate communications positions at companies including Health Net, Valeant Pharmaceuticals and WellPoint Health Networks. “I am excited to welcome Angie to the Veracyte team. Her more than 20 years of investor relations and communications experience, as well as her strong leadership skills and health care bac
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount? [Yahoo! Finance]Yahoo! Finance
- Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View [Yahoo! Finance]Yahoo! Finance
- Veracyte, Inc. (NASDAQ: VCYT) had its price target lowered by analysts at Needham & Company LLC from $33.00 to $27.00. They now have a "buy" rating on the stock.MarketBeat
- Veracyte Announces First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
VCYT
Earnings
- 5/7/24 - Beat
VCYT
Sec Filings
- 5/8/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 4/25/24 - Form ARS
- VCYT's page on the SEC website